Skip Navigation

Laparoscopic liver resection

Guidance issued Guidance issued
 
IP Guidance Number: IPG135
 
Summary:

The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on laparoscopic liver resection.

Description:
The most common indication for laparoscopic liver resection is a solitary liver metastasis from a colorectal cancer, but it may also be used for hepatocellular carcinoma (HCC) and for benign liver tumours or cysts.

Open surgical resection, to remove the affected part of the liver, is the standard treatment for patients with localised colorectal liver metastases and HCC. This procedure is performed through a large incision across the abdomen. A number of alternative therapies have also been developed, including hepatic artery infusion chemotherapy, percutaneous ethanol injection, cryoablation, microwave coagulation therapy, laser-induced thermotherapy, and radiofrequency ablation.

Benign liver tumours are usually treated only if they are causing symptoms. The standard treatment is open surgical resection.

Laparoscopic liver resection is performed under a general anaesthetic. The abdomen is insufflated with carbon dioxide and a number of small incisions are made to provide access for the laparoscope and surgical instruments. The resected liver is enclosed in a bag and removed,  through a small incision in the umbilical area.

Hand-assisted laparoscopic liver resection allows the surgeon to place one hand in the abdomen while maintaining the pneumoperitoneum required for laparoscopy. An additional small incision is made which is just large enough for the surgeon’s hand and an airtight ‘sleeve’ device is used to form a seal around the incision.

Arrangements:

Other (see guidance)

Topic Area:

Cancer
Digestive system

Specialty:

Clinical oncology
Gastro-enterology
Medical oncology

Specialist advice has
been sought from:

British Society of Gastroenterology

Association of Laparoscopic Surgeons of Great Britain & Ireland

Pancreatic Society of Great Britain and Ireland

British Association of Surgical Oncology

Date notified to NICE: 24 September 2004
Provisional Consultation Date: April 2005
Guidance Publication Date: 27 July 2005
Contact Details:
Project Manager
(for general enquiries or comments)
Ben Doak
ip@nice.org.uk
Technical Lead
(for procedure specific enquiries or comments)
Helen Gallo
ip@nice.org.uk
Contact Address:

Interventional Procedures Programme
National Institute for Health and Clinical Excellence
MidCity Place
71 High Holborn
London
WC1V 6NA


Links:

Search NICE guidance


Advanced guidance search

Related guidance

Click the links below to see guidance on similar topics